14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of VXRT
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Strong day for Vaxart stock price on Thursday rising 6.91% to $0.749
(Updated on May 02, 2024)

Sell candidate since Apr 04, 2024 Loss -33.72% PDF

The Vaxart stock price gained 6.91% on the last trading day (Thursday, 2nd May 2024), rising from $0.701 to $0.749. During the last trading day the stock fluctuated 8.55% from a day low at $0.690 to a day high of $0.749. The price has been going up and down for this period, and there has been a -11.08% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 520 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $921.83 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -32.34% during the next 3 months and, with a 90% probability hold a price between $0.416 and $0.745 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

VXRT Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 25, 2024, and so far it has risen 13.76%. Further rise is indicated until a new top pivot has been found. Vaxart has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Vaxart stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $1.00. On a fall, the stock will find some support from the short-term average at $0.708. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Vaxart stock

Vaxart finds support from accumulated volume at $0.715 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0590 between high and low, or 8.55%. For the last week, the stock has had daily average volatility of 7.91%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (VXRT) For The Upcoming Trading Day Of Friday 3rd

For the upcoming trading day on Friday, 3rd we expect Vaxart to open at $0.729, and during the day (based on 14 day Average True Range), to move between $0.672 and $0.83, which gives a possible trading interval of +/-$0.0774 (+/-10.34%) up or down from last closing price. If Vaxart takes out the full calculated possible swing range there will be an estimated 20.68% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.756 (0.88%) than the support at $0.715 (4.58%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Vaxart stock A Buy?

Vaxart holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.267 Sell Candidate Unchanged

Predicted Opening Price for Vaxart of Friday, May 3, 2024

Fair opening price May 3, 2024 Current price
$0.729 ( 2.63%) $0.749

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for VXRT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.788 5.25 %
R2 0.766 2.24 %
R1 0.752 0.383 %
Current price: 0.749
Support S1 0.707 -5.63 %
S2 0.693 -7.49 %
S3 0.670 -10.50 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.91 21.51 %
R2 0.91 21.38 %
R1 0.756 0.88 %
Current price 0.749
Support S1 0.715 -4.58%
S2 0.710 -5.25%
S3 0.658 -12.10%

VXRT Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Oct 25, 2012 Nov 09, 2012 Feb 14, 2018 $12.19 143.39%

FAQ

What is the symbol for Vaxart Stock and on which exchange is it traded?
The symbol for Vaxart is VXRT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Vaxart Stock?
Vaxart holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Vaxart Stock?
Vaxart Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Vaxart Stock.

What's the current price of Vaxart Stock?
As of the end of day on the May 02, 2024, the price of an Vaxart (VXRT) share was $0.749.

What is the 52-week high and low for Vaxart Stock?
The 52-week high for Vaxart Stock is $1.59 and the 52-week low is $0.530.

What is the market capitalization of Vaxart Stock?
As of the May 02, 2024, the market capitalization of Vaxart is 132.452M.

When is the next earnings date for Vaxart?
The upcoming earnings date for Vaxart is Aug 01, 2024.
Click to get the best stock tips daily for free!

About Vaxart

Vaxart Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; seasonal influenza vaccine, which is in Phase II clinical trial for the t... VXRT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT